BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bouzgarrou N, Hassen E, Bahri O, Gabbouj S, Mami NB, Triki H, Chouchane L. Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients. Hepatol Int 2011;5:681-7. [PMID: 21484147 DOI: 10.1007/s12072-010-9232-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Ben Selma W, Laribi AB, Alibi S, Boukadida J. Association of an IFN-γ variant with susceptibility to chronic hepatitis B by the enhancement of HBV DNA replication. Cytokine 2021;143:155525. [PMID: 33896709 DOI: 10.1016/j.cyto.2021.155525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Talaat RM, Elsharnoby S, Abdelkhalek MS, El-Shenawy SZ, Elmasry S. The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes' Polymorphism on Risk of Hepatitis C Virus-Related Liver Cirrhosis. Immunol Invest 2021;:1-17. [PMID: 33445993 DOI: 10.1080/08820139.2020.1869251] [Reference Citation Analysis]
3 Sheneef A, Esmat MM, Mohammad AN, Mahmoud AA, Moghazy HM, Noureldin AK. Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk. J Interferon Cytokine Res 2017;37:175-80. [PMID: 28387594 DOI: 10.1089/jir.2016.0106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Sghaier I, Mouelhi L, Rabia NA, Ghazoueni E, Almawi WY, Loueslati BY. IL-10 and IL-28B gene variants as predictors of sustained response to peginterferon and ribavirin therapy in chronic HCV infection. Cytokine 2017:S1043-4666(17)30073-X. [PMID: 28391873 DOI: 10.1016/j.cyto.2017.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Zhu SL, Zhao Y, Hu XY, Luo T, Chen ZS, Zhang Y, Yang SH, Zhou L, Li LQ. Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma. Sci Rep 2016;6:39404. [PMID: 28000712 DOI: 10.1038/srep39404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Aroucha DC, Carmo RF, Vasconcelos LRS, Lima RE, Mendonça TF, Arnez LE, Cavalcanti MDSM, Muniz MTC, Aroucha ML, Siqueira ER, Pereira LB, Moura P, Pereira LMMB, Coêlho MR. TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals: TNF-α and IL-10 Polymorphisms and HCC. J Med Virol 2016;88:1587-95. [DOI: 10.1002/jmv.24501] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
7 Sun Y, Lu Y, Xie L, Deng Y, Li S, Qin X. Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population. Cancer Cell Int 2015;15:35. [PMID: 25861244 DOI: 10.1186/s12935-015-0184-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
8 Fadlalla FA, Mohamoud YA, Mumtaz GR, Abu-Raddad LJ. The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses. PLoS One. 2015;10:e0121873. [PMID: 25803848 DOI: 10.1371/journal.pone.0121873] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
9 Guo PF, Jin J, Sun X. Influence of IL10 gene polymorphisms on the severity of liver fibrosis and susceptibility to liver cirrhosis in HBV/HCV-infected patients. Infect Genet Evol 2015;30:89-95. [PMID: 25514046 DOI: 10.1016/j.meegid.2014.12.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
10 Yamaguchi T, Yoshida K, Murata M, Matsuzaki K. Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases. World J Gastroenterol 2014; 20(35): 12381-12390 [PMID: 25253939 DOI: 10.3748/wjg.v20.i35.12381] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Tarragô AM, da Costa AG, Pimentel JP, Gomes ST, Freitas FB, Lalwani P, de Araújo AR, Victória Fda S, Victória MB, Vallinoto AC, Sadahiro A, Teixeira-Carvalho A, Martins-Filho OA, Malheiro A. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients. Hum Immunol 2014;75:1075-83. [PMID: 25193024 DOI: 10.1016/j.humimm.2014.08.198] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]